Yasin Keshvargar
Lawyers
Filters
Precigen sale of Trans Ova Genetics to URUS
We are advising Precigen on the transaction
Gracell Biotechnologies at-the-market offering
The ADSs are listed on the Nasdaq Global Select Market
Ormat Technologies $375 million convertible senior notes offering
The 2.5% convertible notes are due 2027
Grupo Aval spinoff of BAC Holding International
We advised Grupo Aval on the unregistered spinoff of a 75% equity stake in its indirect subsidiary
Grupo Aval consent solicitation
We advised Grupo Aval on its consent solicitation
Stanley Black & Decker $1 billion senior notes offering
The 2.3% investment-grade notes are due 2025 and the 3% investment-grade notes are due 2032
Perion Network $180 million follow-on offering
We advised Perion on the offering of ordinary shares
GT Gettaxi business combination with Rosecliff Acquisition
We are advising GT Gettaxi on the transaction
Inventiva at-the-market offering
We advised the sales agent on the SEC-registered offering of ADSs
On Running $858.4 million IPO
We advised On Holding on its IPO and NYSE listing